Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China flag China · Delayed Price · Currency is CNY
13.64
-0.94 (-6.45%)
Sep 10, 2026, 12:44 PM CST

SHE:002907 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
786.5815.21764.14680.84774.72837.23
Other Revenue
12.2811.9310.6810.710.478.91
798.78827.14774.82691.54785.18846.14
Revenue Growth
-0.01%6.75%12.04%-11.93%-7.20%-4.12%
Cost of Revenue
340.46353.96332.91312.45320.55400.53
Gross Profit
458.32473.18441.91379.1464.63445.61
Selling, General & Admin
296.69317.2308.36263.88292.53297.82
Research & Development
85.9489.7659.1378.1258.8241.72
Other Operating Expenses
17.213.2212.1111.0112.3411.58
Operating Expenses
402.18420.38381.01351.31367.04350.65
Operating Income
56.1452.860.927.7897.5994.95
Interest Expense
-1.84-0.14--0.95-14.42-18.22
Interest & Investment Income
-14.7910.329.8111.516.4
Currency Exchange Gain (Loss)
0.020.020-0--
Other Non Operating Income (Expenses)
13.11-0.30.27-0.17-0.03-0.03
EBT Excluding Unusual Items
67.4367.1771.4936.4894.6493.11
Gain (Loss) on Sale of Investments
1.931.421.38-4.67-2.61-1.33
Gain (Loss) on Sale of Assets
10.2510.25-0.06--0.01
Asset Writedown
-0.44-0.44-0.03-2.37-0.17-
Other Unusual Items
3.97-0.9420.613.316.3711.65
Pretax Income
83.1377.4693.4442.8108.24103.42
Income Tax Expense
24.2522.2516.7110.19.8411.64
Earnings From Continuing Operations
58.8855.2176.7332.798.491.78
Minority Interest in Earnings
15.249.88----
Net Income
74.1265.0976.7332.798.491.78
Net Income to Common
74.1265.0976.7332.798.491.78
Net Income Growth
-11.20%-15.17%134.66%-66.77%7.21%-22.99%
Shares Outstanding (Basic)
418417418418403401
Shares Outstanding (Diluted)
418417418418403401
Shares Change
-0.05%-0.05%0.02%3.60%0.49%0.06%
EPS (Basic)
0.180.160.180.080.240.23
EPS (Diluted)
0.180.160.180.080.240.23
EPS Growth
-11.15%-15.13%134.61%-67.92%6.69%-23.04%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
60.5547.68145.62126.52-47.5726.21
Free Cash Flow Per Share
0.140.110.350.30-0.120.07
Dividend Per Share
0.0750.0750.0850.0500.0700.050
Dividend Growth
-11.77%-11.77%70.00%-28.57%40.00%78.57%
Gross Margin
57.38%57.21%57.03%54.82%59.17%52.66%
Operating Margin
7.03%6.38%7.86%4.02%12.43%11.22%
Profit Margin
9.28%7.87%9.90%4.73%12.53%10.85%
Free Cash Flow Margin
7.58%5.76%18.79%18.30%-6.06%3.10%
EBITDA
145.81138.5147.74109.68172.13164.7
EBITDA Margin
18.25%16.74%19.07%15.86%21.92%19.46%
D&A For EBITDA
89.6785.786.8481.974.5469.74
EBIT
56.1452.860.927.7897.5994.95
EBIT Margin
7.03%6.38%7.86%4.02%12.43%11.22%
Effective Tax Rate
29.17%28.72%17.89%23.59%9.09%11.25%
Revenue as Reported
798.78827.14774.82691.54785.18846.14